Dis-Chem Pharmacies Limited (DCP) Earnings Call Transcripts

Dis-Chem Pharmacies Limited's Latest Earnings Call - May 29, 2026

Dis-Chem Pharmacies Limited reported strong financial results for the fiscal year ending February 28, 2026, with revenue growth of 9.3% to ZAR 36.6 billion and total income growth of 9.6%. The company launched its Better Rewards program, which has significantly driven sales and market share gains, particularly in the pharmacy and healthcare categories. Management anticipates continued growth, projecting a total income margin increase to 32.0% post-year-end, indicating strong operational leverage and sustainability of the Better Rewards initiative.

Reported metrics

Guidance from management

Management expects continued revenue growth in FY '27, with a total income margin projected to increase to 32.0%. They anticipate the Better Rewards program will sustain its momentum despite economic challenges.

What management said

So Capitec have a bigger market share in houses than they did previously. So simply speaking, more people are taking out Capitec cards as and when they are paying at our point of sale. And likewise, we have a bigger market share base of the Capitec pharmacy spend than we used to previously. So the partnership is working well for both partners. .

I mean I'll just explain that. The ZAR 115 million was effectively benefit points that were part of the old program cycling through our income statement. So they legitimately don't recur because they don't exist to recur. That program has been retired. So they are legitimately nonrecurring expenses. And the way that we frame bigly as I said, is we expect net positive incremental returns off that base. That invested b...

What analysts pressed on

Analysts expressed concerns regarding the sustainability of the Better Rewards program amid increasing competition and potential vendor exit risks. They also questioned the impact of economic constraints on consumer spending and overall retail performance.

Main topics on the call

• Better Rewards Program Impact — The Better Rewards program has driven retail revenue growth of 9.6% since its launch, with participating brands seeing a 12% increase in value growth. Management noted, "the sustainability of the mechanism of funding" is...
• Core Retail Profitability — Core retail profitability increased to 27.1%, supported by strong revenue growth and effective cost control, with like-for-like payroll costs maintained at 3.5%. Management stated, "the relationship between like-for-like...
• Wholesale Revenue Growth — Wholesale revenue grew by 11.3%, driven by the TLC franchise model, which expanded from 240 to 280 stores. Management highlighted that the TLC franchise revenue increased by 16.4%, indicating strong market demand.
• Investment in Ecosystem — Management invested ZAR 330 million in the ecosystem, which is expected to yield positive returns in FY '27. They emphasized that this investment is crucial for transitioning to an integrated healthcare provider.

Read the full Dis-Chem Pharmacies Limited transcript (May 29, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 13 Dis-Chem Pharmacies Limited earnings call transcripts on record, spanning May 20, 2020 to May 29, 2026. Based on this history, Dis-Chem Pharmacies Limited reports semi-annually. The most recent call on file is dated May 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

DCP

Exchange

JSE

Country

ZA

Sector

Consumer Staples

Industry

Consumer Staples Distribution and Retail

Calls on record

13

First call

May 20, 2020

Most recent

May 29, 2026

Reporting cadence

semi-annually